The 21-valent pneumococcal conjugate vaccine V116 is well tolerated in adults living with HIV and induces immunity to all 21 ...
A 43-year-old woman with bipolar disorder and advanced HIV infection was admitted to this hospital because of depressed mood, ...
Early initiation of antiretroviral therapy does not provide significant cardiovascular benefits compared with delayed ...
Merck announces new data from phase 3 trials of investigational, once-daily, oral, two-drug regimen of DOR/ISL in adults with virologically suppressed HIV-1 infection: Rahway, New ...
If PIFELTRO is coadministered with rifabutin, increase PIFELTRO dosage to one tablet twice daily (approximately 12 hours apart). Consult the full Prescribing Information prior to and during treatment ...
More information: Mehdi Benlarbi et al, CD4 T cell counts are inversely correlated with anti-gp120 cluster A antibodies in ...
The Christian Post on MSN
Nelson Makanda wants to train 200,000 pastors to meet Africa’s Evangelical boom
On a wet Thursday in September, Rev Nelson Makanda was busy appealing to the United States President s Emergency Plan for ...
The PLHIVs under National Empowerment Network of People Living with HIV/AIDS in Kenya (NEPHAK) also want clarity on user fees ...
Individuals with post-COVID syndrome had higher immune cell counts after receiving exercise-based rehabilitation vs. usual ...
Health and Me on MSN
What Is ‘Bluetoothing’? The Alarming Drug Trend Behind Rising HIV Cases
Bluetoothing is a disturbing drug trend where users inject the blood of someone who is already high, hoping to feel the same ...
Data from the CLARITY study will provide insights on acceptability and tolerability of single-dose cabotegravir and lenacapavir long-acting injections Four-year analysis from the OPERA cohort ...
MicroRNAs: Following a single 4-hour HP treatment, decreases were observed in seven out of ten miRNAs examined in two of the three participants. MicroRNAs are one component of the cargo of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results